Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 2 (2019)

Analytical method development & validation of metformin, pioglitazone & glimepiride by RP-HPLC in tablet dosage forms

Author(s):
KS Nataraj, A Srinivasa Rao, KV Nagamani, P Divya and B Renukachandrasekhar
Abstract:
A new, simple, precise, accurate and reproducible RP-HPLC method for Simultaneous estimation of bulk and pharmaceutical formulations. Separation of Metformin, Pioglitazone and Glimepiride was successfully achieve WATERS, C18, 25cmx4.6mm, 5µm or equivalent in an isocratic mode utilizing OPA(ortho phosphoric acid) : Methanol (60:40) at a flow rate of 1.0mL/min and elute was monitored at 273nm, with a retention time of 4.7 minutes for Metformin, 6.4 minutes for Pioglitazone and 9.7 minutes Glimepiride. The method was validated for linearity, accuracy, precision, detection limit, quantification limit, specificity, system suitability and solution stability. Results of all validation parameters were within the limits as per ICH guidelines.
Pages: 266-273  |  1081 Views  248 Downloads


The Pharma Innovation Journal
How to cite this article:
KS Nataraj, A Srinivasa Rao, KV Nagamani, P Divya, B Renukachandrasekhar. Analytical method development & validation of metformin, pioglitazone & glimepiride by RP-HPLC in tablet dosage forms. Pharma Innovation 2019;8(2):266-273.

Call for book chapter